Gausar analyzer () was used to predict the toxicity of these molecules. It analyzes the molecules on the basis of their toxicity while administering the following molecules through a specific route of administration and classification on the basis of OECD project as shown in Table . The results showed that the DN cannot be administered peritoneally with the LD50 log10 value of 0.574 mmol/kg whereas the PB had an oral toxic profile with the value of LD50 log10 of -0.391 mmol/kg. DN's applicability domain was in oral, subcutaneous and intravenous rat models. The PB's applicability domain for human consumption was peritoneal, intravenous and subcutaneous rat models. The results are shown in Table .